Verismo Therapeutics is a biotechnology company that develops CAR T cell therapy for the treatment of solid tumors.
Verismo Therapeutics has raised $28.0M in total funding. The most recent round was Corporate Round. The last funding was announced in April 2026.
Verismo Therapeutics's investors include HLB innovation, BRV Capital Management, Hong Leong Bank, ScaleReady, Institute for Follicular Lymphoma Innovation.
Verismo Therapeutics is headquartered in Philadelphia, United States.
Verismo Therapeutics is a biotechnology company that develops CAR T cell therapy for the treatment of solid tumors.
Verismo Therapeutics is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Verismo Therapeutics — Funding & Investors." VCBacked, April 15, 2026, https://www.vcbacked.co/company/verismo-therapeutics. Accessed September 15, 2026.
VCBacked. (2026). Verismo Therapeutics — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/verismo-therapeutics
{{cite web |title=Verismo Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/verismo-therapeutics |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated